{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:44:59Z","timestamp":1761824699572,"version":"build-2065373602"},"reference-count":55,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Medical Sciences"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.advms.2022.09.004","type":"journal-article","created":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T14:56:24Z","timestamp":1663858584000},"page":"364-378","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Exploring a 7-gene prognostic model based on ferroptosis for efficiently guiding immunotherapy in melanoma patients"],"prefix":"10.1016","volume":"67","author":[{"given":"Xin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changrui","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zigang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.advms.2022.09.004_bib1","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA A Cancer J Clin"},{"issue":"10151","key":"10.1016\/j.advms.2022.09.004_bib2","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(18)31559-9","volume":"392","author":"Schadendorf","year":"2018","journal-title":"Melanoma. Lancet."},{"issue":"12","key":"10.1016\/j.advms.2022.09.004_bib3","doi-asserted-by":"crossref","first-page":"3675","DOI":"10.37358\/RC.18.12.6817","article-title":"Markers usefulness in the melanic metastatic cellular epitops identification in the sentinel lymph node","volume":"69","author":"Endres","year":"2018","journal-title":"Rev. Chim.[internet]"},{"issue":"21","key":"10.1016\/j.advms.2022.09.004_bib4","doi-asserted-by":"crossref","first-page":"26025","DOI":"10.1007\/s11356-020-09028-0","article-title":"Overview of the anticancer activity of withaferin A, an active constituent of the Indian ginseng Withania somnifera","volume":"27","author":"Sivasankarapillai","year":"2020","journal-title":"Environ Sci Pollut Res Int"},{"issue":"9","key":"10.1016\/j.advms.2022.09.004_bib5","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.3390\/molecules26092407","article-title":"Withaferin A-A promising phytochemical compound with multiple results in dermatological diseases","volume":"26","author":"Bungau","year":"2021","journal-title":"Molecules"},{"issue":"20","key":"10.1016\/j.advms.2022.09.004_bib6","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1056\/NEJMoa1502583","article-title":"The genetic evolution of melanoma from precursor lesions","volume":"373","author":"Shain","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.advms.2022.09.004_bib7","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2015.20","article-title":"How cell death shapes cancer","volume":"6","author":"Labi","year":"2015","journal-title":"Cell Death Dis"},{"issue":"7","key":"10.1016\/j.advms.2022.09.004_bib8","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.3390\/molecules27072129","article-title":"Ferroptosis: a new road towards cancer management","volume":"27","author":"Bano","year":"2022","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.advms.2022.09.004_bib9","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/pcmr.13009","article-title":"The role of ferroptosis in melanoma","volume":"35","author":"Talty","year":"2022","journal-title":"Pigment Cell Melanoma Res"},{"issue":"1","key":"10.1016\/j.advms.2022.09.004_bib10","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3390\/cancers12010164","article-title":"Ferroptosis in cancer cell biology","volume":"12","author":"Bebber","year":"2020","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.advms.2022.09.004_bib11","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13045-019-0720-y","article-title":"Ferroptosis, a new form of cell death: opportunities and challenges in cancer","volume":"12","author":"Mou","year":"2019","journal-title":"J\u00a0Hematol Oncol"},{"key":"10.1016\/j.advms.2022.09.004_bib12","doi-asserted-by":"crossref","first-page":"992","DOI":"10.3389\/fphar.2017.00992","article-title":"The role of ferroptosis in cancer development and treatment response","volume":"8","author":"Lu","year":"2017","journal-title":"Front Pharmacol"},{"issue":"7","key":"10.1016\/j.advms.2022.09.004_bib13","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/s41568-019-0149-1","article-title":"Ferroptosis at the crossroads of cancer-acquired drug resistance and immune evasion","volume":"19","author":"Friedmann Angeli","year":"2019","journal-title":"Nat Rev Cancer"},{"issue":"7755","key":"10.1016\/j.advms.2022.09.004_bib14","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-019-1170-y","article-title":"CD8(+) T cells regulate tumour ferroptosis during cancer immunotherapy","volume":"569","author":"Wang","year":"2019","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.advms.2022.09.004_bib15","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1158\/2159-8290.CD-19-0338","article-title":"Radiotherapy and immunotherapy promote tumoral lipid oxidation and ferroptosis via synergistic repression of SLC7A11","volume":"9","author":"Lang","year":"2019","journal-title":"Cancer Discov"},{"issue":"5","key":"10.1016\/j.advms.2022.09.004_bib16","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.advms.2022.09.004_bib17","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/hep.28251","article-title":"Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells","volume":"63","author":"Sun","year":"2016","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.advms.2022.09.004_bib18","doi-asserted-by":"crossref","first-page":"517","DOI":"10.18632\/oncoscience.160","article-title":"Identification of artesunate as a specific activator of ferroptosis in pancreatic cancer cells","volume":"2","author":"Eling","year":"2015","journal-title":"Oncoscience"},{"key":"10.1016\/j.advms.2022.09.004_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.4706","article-title":"Identification and validation of a ferroptosis-related gene signature for predicting survival in skin cutaneous melanoma","author":"Ping","year":"2022","journal-title":"Cancer Med"},{"issue":"3","key":"10.1016\/j.advms.2022.09.004_bib20","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2217\/bmm-2021-0998","article-title":"Ferroptosis-related genes are candidate diagnostic and prognostic biomarkers for skin cutaneous melanoma","volume":"16","author":"Jing","year":"2022","journal-title":"Biomarkers Med"},{"key":"10.1016\/j.advms.2022.09.004_bib21","article-title":"Construction and validation of a ferroptosis-related prognostic signature for melanoma based on single-cell RNA sequencing","volume":"10","author":"Liu","year":"2022","journal-title":"Front Cell Dev Biol"},{"issue":"7","key":"10.1016\/j.advms.2022.09.004_bib22","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.cell.2015.05.044","article-title":"Genomic classification of cutaneous melanoma","volume":"161","year":"2015","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.advms.2022.09.004_bib23","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1093\/bioinformatics\/btq170","article-title":"ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking","volume":"26","author":"Wilkerson","year":"2010","journal-title":"Bioinformatics"},{"issue":"4","key":"10.1016\/j.advms.2022.09.004_bib24","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","article-title":"The immune landscape of cancer","volume":"48","author":"Thorsson","year":"2018","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.advms.2022.09.004_bib25","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nbt.2514","article-title":"Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples","volume":"31","author":"Cibulskis","year":"2013","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.advms.2022.09.004_bib26","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/978-1-4939-7493-1_12","article-title":"Profiling tumor infiltrating immune cells with CIBERSORT","volume":"1711","author":"Chen","year":"2018","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.advms.2022.09.004_bib27","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1038\/ncomms3612","article-title":"Inferring tumour purity and stromal and immune cell admixture from expression data","volume":"4","author":"Yoshihara","year":"2013","journal-title":"Nat Commun"},{"issue":"7","key":"10.1016\/j.advms.2022.09.004_bib28","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"Limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"10.1016\/j.advms.2022.09.004_bib29","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS"},{"key":"10.1016\/j.advms.2022.09.004_bib30","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data","volume":"14","author":"H\u00e4nzelmann","year":"2013","journal-title":"BMC Bioinf"},{"issue":"7269","key":"10.1016\/j.advms.2022.09.004_bib31","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature08460","article-title":"Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1","volume":"462","author":"Barbie","year":"2009","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.advms.2022.09.004_bib32","first-page":"1","article-title":"Regularization paths for generalized linear models via coordinate descent","volume":"33","author":"Friedman","year":"2010","journal-title":"J\u00a0Stat Software"},{"issue":"7","key":"10.1016\/j.advms.2022.09.004_bib33","doi-asserted-by":"crossref","first-page":"136","DOI":"10.21037\/atm.2016.03.35","article-title":"Variable selection with stepwise and best subset approaches","volume":"4","author":"Zhang","year":"2016","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.advms.2022.09.004_bib34","doi-asserted-by":"crossref","DOI":"10.1093\/database\/bax094","article-title":"HisgAtlas 1.0: a human immunosuppression gene database","author":"Liu","year":"2017","journal-title":"Database (Oxford)"},{"issue":"2","key":"10.1016\/j.advms.2022.09.004_bib35","first-page":"130","article-title":"Decision tree methods: applications for classification and prediction","volume":"27","author":"Song","year":"2015","journal-title":"Shanghai Arch Psychiatry"},{"issue":"6","key":"10.1016\/j.advms.2022.09.004_bib36","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.eururo.2018.08.038","article-title":"Reporting and interpreting decision curve analysis: a guide for investigators","volume":"74","author":"Van Calster","year":"2018","journal-title":"Eur Urol"},{"issue":"5195","key":"10.1016\/j.advms.2022.09.004_bib37","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1126\/science.7809629","article-title":"A\u00a0phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules","volume":"267","author":"Kovacsovics-Bankowski","year":"1995","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.advms.2022.09.004_bib38","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.3109\/07357900902769749","article-title":"Cell adhesion molecules: role and clinical significance in cancer","volume":"27","author":"Makrilia","year":"2009","journal-title":"Cancer Invest"},{"issue":"12","key":"10.1016\/j.advms.2022.09.004_bib39","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1038\/s41419-019-2143-7","article-title":"Aldo-keto reductases protect metastatic melanoma from ER stress-independent ferroptosis","volume":"10","author":"Gagliardi","year":"2019","journal-title":"Cell Death Dis"},{"issue":"1","key":"10.1016\/j.advms.2022.09.004_bib40","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/s41467-020-14324-x","article-title":"Nedd4 ubiquitylates VDAC2\/3 to suppress erastin-induced ferroptosis in melanoma","volume":"11","author":"Yang","year":"2020","journal-title":"Nat Commun"},{"issue":"6","key":"10.1016\/j.advms.2022.09.004_bib41","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/nrclinonc.2016.65","article-title":"The future of cancer treatment: immunomodulation, CARs and combination immunotherapy","volume":"13","author":"Khalil","year":"2016","journal-title":"Nat Rev Clin Oncol"},{"issue":"8","key":"10.1016\/j.advms.2022.09.004_bib42","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/s41577-018-0009-3","article-title":"An early history of T cell-mediated cytotoxicity","volume":"18","author":"Golstein","year":"2018","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"10.1016\/j.advms.2022.09.004_bib43","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1186\/s12885-021-08083-1","article-title":"Gene expression and immune infiltration in melanoma patients with different mutation burden","volume":"21","author":"Wang","year":"2021","journal-title":"BMC Cancer"},{"issue":"2","key":"10.1016\/j.advms.2022.09.004_bib44","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41416-020-01048-4","article-title":"Cytotoxic CD8(+) T cells in cancer and cancer immunotherapy","volume":"124","author":"Raskov","year":"2021","journal-title":"Br J Cancer"},{"issue":"6","key":"10.1016\/j.advms.2022.09.004_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/cells8060562","article-title":"TTYH1 and TTYH2 serve as lrrc8a-independent volume-regulated anion channels in cancer cells","volume":"8","author":"Bae","year":"2019","journal-title":"Cells"},{"issue":"11","key":"10.1016\/j.advms.2022.09.004_bib46","doi-asserted-by":"crossref","first-page":"8333","DOI":"10.1007\/s13277-015-3584-y","article-title":"SEMA6A is a prognostic biomarker in glioblastoma","volume":"36","author":"Zhao","year":"2015","journal-title":"Tumour Biol"},{"issue":"6","key":"10.1016\/j.advms.2022.09.004_bib47","doi-asserted-by":"crossref","first-page":"R965","DOI":"10.1186\/bcr1329","article-title":"Rac1 and Rac3 isoform activation is involved in the invasive and metastatic phenotype of human breast cancer cells","volume":"7","author":"Baugher","year":"2005","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.advms.2022.09.004_bib48","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3389\/fmolb.2020.00218","article-title":"RAC3 promotes proliferation, migration and invasion via PYCR1\/JAK\/STAT signaling in bladder cancer","volume":"7","author":"Cheng","year":"2020","journal-title":"Front Mol Biosci"},{"issue":"13","key":"10.1016\/j.advms.2022.09.004_bib49","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.2174\/0929867322666150209152057","article-title":"Hck inhibitors as potential therapeutic agents in cancer and HIV infection","volume":"22","author":"Musumeci","year":"2015","journal-title":"Curr Med Chem"},{"issue":"4","key":"10.1016\/j.advms.2022.09.004_bib50","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.ccell.2017.03.006","article-title":"Inhibition of hematopoietic cell Kinase activity suppresses myeloid cell-mediated colon cancer progression","volume":"31","author":"Poh","year":"2017","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.advms.2022.09.004_bib51","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1150398","article-title":"Maraviroc decreases CCL8-mediated migration of CCR5(+) regulatory T cells and reduces metastatic tumor growth in the lungs","volume":"5","author":"Halvorsen","year":"2016","journal-title":"OncoImmunology"},{"issue":"17","key":"10.1016\/j.advms.2022.09.004_bib52","doi-asserted-by":"crossref","first-page":"5191","DOI":"10.1158\/1078-0432.CCR-18-1550","article-title":"Immunotherapy of melanoma: facts and hopes","volume":"25","author":"Weiss","year":"2019","journal-title":"Clin Cancer Res"},{"issue":"17","key":"10.1016\/j.advms.2022.09.004_bib53","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1200\/JCO.2014.56.2736","article-title":"Pooled analysis of long-term survival data from phase II and phase III trials of ipilimumab in unresectable or metastatic melanoma","volume":"33","author":"Schadendorf","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.advms.2022.09.004_bib54","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1001\/jamaoncol.2018.4514","article-title":"Survival outcomes in patients with previously untreated BRAF wild-type Advanced melanoma treated with nivolumab therapy: three-year follow-up of a randomized phase 3 trial","volume":"5","author":"Ascierto","year":"2019","journal-title":"JAMA Oncol"},{"issue":"15_suppl","key":"10.1016\/j.advms.2022.09.004_bib55","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2018.36.15_suppl.9503","article-title":"4-year survival and outcomes after cessation of pembrolizumab (pembro) after 2-years in patients (pts) with ipilimumab (ipi)-naive advanced melanoma in KEYNOTE-006","volume":"36","author":"Long","year":"2018","journal-title":"J\u00a0Clin Oncol"}],"container-title":["Advances in Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1896112622000384?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1896112622000384?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:42:32Z","timestamp":1761824552000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1896112622000384"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":55,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S1896112622000384"],"URL":"https:\/\/doi.org\/10.1016\/j.advms.2022.09.004","relation":{},"ISSN":["1896-1126"],"issn-type":[{"type":"print","value":"1896-1126"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring a 7-gene prognostic model based on ferroptosis for efficiently guiding immunotherapy in melanoma patients","name":"articletitle","label":"Article Title"},{"value":"Advances in Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.advms.2022.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier B.V. on behalf of Medical University of Bialystok.","name":"copyright","label":"Copyright"}]}}